Clinical Trials Browser

Phase 3 × Interventional × Lambert-Eaton Myasthenic Syndrome × Clear all

NCT01377922 2018-01-04

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Phase 3 Completed

38 enrolled 12 charts

Lambert-Eaton Myasthenic Syndrome